Clinical Trials Browser

Carcinoma, Ovarian Epithelial, Adenocarcinoma, Bile Duct Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Carcinoma, Small Cell, Carcinoma, Ductal, Small Cell Lung Carcinoma, Inflammatory Breast Neoplasms

Clinical Trials

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

MK-3475-E90

Safety/Tolerability, PK and Efficacy of IMB071703 Injection in Patients With Advanced Solid Tumors

Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors

Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors

Clinical Study of SM3321 With Solid Tumors

Study of BEBT-607 Tablets in The Treatment of Advanced or Metastatic Solid Tumors With KRAS G12C Mutation

Minnelide 101

Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T

HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors

A Study of TY-2136b in Patients With Advanced Solid Tumors Harboring ALK, ROS1 or NTRK1-3 Alterations

Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic Cancer

The Clinical Trial to Evaluate the Pharmacokinetics and Safety of MRTX849 in Patients With Advanced Solid Tumors

SHR-1701 in Subjects With Metastatic or Locally Advanced Solid Tumors

Phase I Study of SHR9146 + SHR-1210 +/- Apatinib in Patients With Advanced Solid Tumors

A Study to Assess PV-10 Chemoablation of Cancer of the Liver

Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors

A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors

A Study of RX108 in Patients With Locally Advanced or Metastatic Solid Tumors

A Phase 1，Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors

A Trial of HRS-8080 Tablets in Metastatic or Local Advanced Breast Cancer of Adults

Study of TJ004309 in Combination With Atezolizumab (Tecentriq®) in Patients With Advanced or Metastatic Cancer

A Phase 1 Study of BPI-28592 in Subjects With Advanced Solid Tumors

Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell Carcinoma

Single Arm Phase I Trail of Autologous Tumor Infiltrating Lymphocyte Injection (GT202) in the Treatment of Metastatic or Recurrent Gynecological Tumors

A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK114

Study of MTB-9655, an Inhibitor of ACSS2, in Patients With Advanced Solid Tumors

SHR-1701 in Metastatic or Locally Advanced Solid Tumors

A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors

ATRiUM

i-GO

Phase 1 Study of HLX10, a Monoclonal Antibody Targeting Programmed Death-1 (PD-1) in Patients With Advanced Solid Tumors

A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma

Study of Alofanib in Patients With Metastatic Gastric Cancer

Phase I Trial of LMP2 Antigen-specific TCR T-cell Therapy for Recurrent and Metastatic NPC Patients

A Safety Study of the Pan-immunotherapy in Patients With Unresectable/Metastatic Solid Tumors or Lymphomas

Intraperitoneal Infusion of EpCAM CAR-T Cell in Advanced Gastric Cancer With Peritoneal Metastasis (WCH-GC-CART)

Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer

Dendritic Killer Cell-based Immunotherapy for Solid Tumors

Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer

Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma

Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors

EVESOR

TIROX

Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer